Xiaofei Wang

813 total citations
41 papers, 536 citations indexed

About

Xiaofei Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofei Wang has authored 41 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofei Wang's work include MicroRNA in disease regulation (13 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (8 papers). Xiaofei Wang is often cited by papers focused on MicroRNA in disease regulation (13 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (8 papers). Xiaofei Wang collaborates with scholars based in China, United Kingdom and United States. Xiaofei Wang's co-authors include Chen Huang, Bo Guo, Jiyu Miao, Dongdong Tong, Tusheng Song, Lei Ni, Liying Liu, Zhenghao Zhao, Lingyu Zhao and Juan Yang and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Energy.

In The Last Decade

Xiaofei Wang

33 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Wang China 14 369 254 58 52 38 41 536
Lihua Zhang China 15 393 1.1× 200 0.8× 63 1.1× 51 1.0× 38 1.0× 41 759
Xiangsheng Yang China 14 345 0.9× 146 0.6× 51 0.9× 43 0.8× 61 1.6× 25 526
Monika M Gladka Netherlands 10 814 2.2× 454 1.8× 56 1.0× 44 0.8× 55 1.4× 22 1.0k
Shambhabi Chatterjee Germany 12 534 1.4× 414 1.6× 45 0.8× 29 0.6× 45 1.2× 29 781
Xiangyu Zhai China 14 253 0.7× 147 0.6× 120 2.1× 84 1.6× 111 2.9× 28 525
Dazhi Wang United States 6 631 1.7× 449 1.8× 20 0.3× 27 0.5× 20 0.5× 11 772
Martina Dreßen Germany 14 521 1.4× 71 0.3× 38 0.7× 54 1.0× 18 0.5× 34 720
Dongchao Lu Germany 8 460 1.2× 339 1.3× 16 0.3× 28 0.5× 27 0.7× 17 625
Xi Luo China 12 387 1.0× 219 0.9× 50 0.9× 31 0.6× 78 2.1× 22 677
Yuanbo Hu China 13 350 0.9× 221 0.9× 133 2.3× 132 2.5× 77 2.0× 35 590

Countries citing papers authored by Xiaofei Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Wang more than expected).

Fields of papers citing papers by Xiaofei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Wang. The network helps show where Xiaofei Wang may publish in the future.

Co-authorship network of co-authors of Xiaofei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Wang. A scholar is included among the top collaborators of Xiaofei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Wang. Xiaofei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Zhu, Lei Xu, Zhimin Wu, et al.. (2025). Glabridin mitigates osteoarthritis progression through modulation of the PI3K/AKT/FOXO3A autophagy axis. Phytomedicine. 148. 157359–157359.
3.
4.
Wu, Zhimin, et al.. (2025). The role of FoxO3a in the pathogenesis of osteoarthritis and its therapeutic applications. Frontiers in Immunology. 16. 1650194–1650194.
5.
Zhou, Jing, Fang Li, Cao Li, et al.. (2025). MeCP2 dysregulation inhibits mitophagy and impairs neural development in cortical organoids. Journal of Advanced Research. 82. 429–448.
7.
Liu, Meng, et al.. (2024). ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma. Acta Dermato Venereologica. 104. adv23805–adv23805. 1 indexed citations
8.
Li, Fang, Xiaofei Wang, Jing Zhang, et al.. (2024). RBM8A, a new target of TEAD4, promotes breast cancer progression by regulating IGF1R and IRS-2. Journal of Translational Medicine. 22(1). 823–823.
9.
Wang, Xiaofei, Yao Lin, Zheng Li, et al.. (2024). ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma. International Journal of Biological Sciences. 20(2). 643–663. 2 indexed citations
10.
Li, Cao, Jinyuan Zhang, Jiyu Miao, et al.. (2024). FUT3 promotes gastric cancer cell migration by synthesizing Lea on ITGA6 and GLG1, affecting adhesion and vesicle distribution. Life Sciences. 359. 123193–123193. 2 indexed citations
11.
Jiang, Ting, Jinfeng Chen, Zhenzhen Wang, et al.. (2023). miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway. Breast Cancer. 30(5). 691–702. 2 indexed citations
12.
Qin, Yannan, Haiqing Zhang, Bo Guo, et al.. (2022). Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder. Journal of Molecular Neuroscience. 72(6). 1274–1292. 19 indexed citations
13.
Li, Fang, Yun Feng, Qiuyu Jiang, et al.. (2022). Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC. Life Sciences. 293. 120327–120327. 21 indexed citations
14.
Wu, Shaobo, Xiang Li, Jing Leng, et al.. (2021). A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets. Critical Reviews in Eukaryotic Gene Expression. 31(4). 35–48. 8 indexed citations
15.
Li, Dan, Yulong Li, Xiaofei Wang, et al.. (2021). miR‐149 Suppresses the Proliferation and Metastasis of Human Gastric Cancer Cells by Targeting FOXC1. BioMed Research International. 2021(1). 1503403–1503403. 7 indexed citations
16.
Wang, Xiaofei, Quan Sun, Xiao Kou, et al.. (2021). Noise immune state of charge estimation of li-ion battery via the extreme learning machine with mixture generalized maximum correntropy criterion. Energy. 239. 122406–122406. 30 indexed citations
17.
Tong, Dongdong, Jing Zhang, Xiaofei Wang, et al.. (2020). MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine. Oncogenesis. 9(11). 99–99. 31 indexed citations
18.
Pan, Yan, Haijun Wu, Xiaofei Wang, et al.. (2019). Rotatable precipitates change the scale-free to scale dependent statistics in compressed Ti nano-pillars. Scientific Reports. 9(1). 3778–3778. 16 indexed citations
19.
Wu, Fei, Yannan Qin, Qiuyu Jiang, et al.. (2019). MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells. Cancer Gene Therapy. 27(10-11). 773–784. 13 indexed citations
20.
Wang, Zhenzhen, Zhenghao Zhao, Yang Yang, et al.. (2018). MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer. Scientific Reports. 8(1). 10119–10119. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026